# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000906709-22-000014
Filing Date
2022-08-05
Accepted
2022-08-04 21:35:53
Documents
64
Period of Report
2022-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | nktr-20220630.htm iXBRL | 10-Q | 1378381
2 | EX-10.1 | nktr2022-06x30xexx101ar201.htm | EX-10.1 | 140792
3 | EX-10.2 | nktr2022-06x30xexx102north.htm | EX-10.2 | 95076
4 | EX-31.1 | nktr2022-06x30xexx311.htm | EX-31.1 | 9510
5 | EX-31.2 | nktr2022-06x30xexx312.htm | EX-31.2 | 9636
6 | EX-32.1 | nktr2022-06x30xexx321.htm | EX-32.1 | 5831
12 |  | image_0a.jpg | GRAPHIC | 106542
| Complete submission text file | 0000906709-22-000014.txt |  | 6111495

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | nktr-20220630.xsd | EX-101.SCH | 43191
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | nktr-20220630_cal.xml | EX-101.CAL | 65493
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | nktr-20220630_def.xml | EX-101.DEF | 175487
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | nktr-20220630_lab.xml | EX-101.LAB | 465603
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | nktr-20220630_pre.xml | EX-101.PRE | 295832
58 | EXTRACTED XBRL INSTANCE DOCUMENT | nktr-20220630_htm.xml | XML | 891390

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 221138386
SIC: 2834 Pharmaceutical Preparations